References
A. B. Lerner, J. D. Case, Y. Takahashi, et al.,J. Am. Chem. Soc.,80, 2587 (1958).
A. B. Lerner and J. D. Case,J. Am. Chem. Soc.,81, 6084–6085 (1959).
J. Axelrod and H. Wessbach,Science,131, 1312–1318 (1960).
S. Pang, G. Brown, L. Grota, et al.,Neuroendocrinology,23, 1–13 (1977).
N. T. Raikhlin, I. M. Kvetnoy, and V. N. Tolkachev,Nature,255, 344–345 (1975).
O. Vakkuri, J. Tervo, R. Luttinen, et al.,Endocrinology,120, 2453–2459 (1987).
W. Pierpaoli, A. Dall Ara, E. Pedrinis, and W. Regelson,Ann. N. Y. Acad. Sci.,621, 291–313 (1991).
R. W. Pelman, G. M. Vaughan, K. L. Sandcock, and M. K. Vaughan,J. Clin. Endocrinol.,37, 341–344 (1973).
J. Beck-Frus, G. Berg, and L. Wetterberg,Ann. N. Y. Acad. Sci.,453, 371–373 (1985).
M. U. Gillete and A. J. Mcarthur,Behav. Brain Res.,73, 135–139 (1995).
A. Lewy, F. A. Wehr, and F. K. Goodwin,Science,210, 1267–1269 (1980).
R. Qwiron,Eur. J. Pharmacol.,102, 559–560 (1984).
C. M. Craft, W. W. Morgan, D. Jones, and R. S. Reiter,J. Pineal Res.,2, 51–66 (1985).
M. D. Rollag,Endocrinology,102, 1–8 (1978).
J. Arendt, C. Bojkowski, and C. Franey,J. Clin. Endocrinol.,60, 1166–1173 (1985).
J. Bergiannaki, T. J. Paparrigopoulos, and C. N. Stefanis,Experientia,52, 253–258 (1996).
M. H. Hastings, G. Vance, and E. Maywood,Experientia,45, 903–1008 (1989).
I. Zhdonova, R. J. Wurtman, H. J. Lynch, et al.,Clin. Pharmacol. Ther.,57, 552–558 (1995).
R. J. Reiter, C. M. Craft, and J. E. Jonson,Endocrinology,109, 1205–1207 (1981).
V. Land, M. Kamemark, and M. Aubert,J. Clin. Endocrinol.,53, 645–650 (1981).
A. Cagnacci and A. Volpe,J. Endocrinol. Invest.,19, 382–411 (1996).
E. S. Rom-Boguslavskaya, V. S. Shcherbakova, and I. V. Komarova,Eksperim. Klin. Farmakol., No. 4, 46–49 (1997).
S. L. Evtushenko,Zh. Nevropatol. Psikhiatr.,94(3), 93–99 (1994).
M. Raffi-El-Idrissi, J. R. Calvo, D. Pozo et al.,J. Neuroimmunol.,57, 171–178 (1995).
G. J. M. Maestroni, A. Conti, and W. Pierpaoli,J. Neuroimmunol.,13, 19–31 (1986).
W. Pierpaoli and C. X. Yi,J. Neuroimmunol.,37, 99–110 (1990).
W. Pegelson and W. Pierpaoli,Cancer Invest.,5, 379–385 (1987).
I. Hansson, R. Holmdahl, and R. Mattson,J. Neuroimmunol.,27, 79–84 (1990).
V. N. Anisimov, A. V. Arutyunyan, and V. Kh. Khavinson,Dokl. Ross. Akad. Nauk,348(2), 265–267 (1996).
N. K. Zenkov, M. I. Dushkin, E. B. Men'shikova, et al.,Byul. Eksp. Biol. Med., No. 10, 399–402 (1996).
K. Kato, J. Murai, S. Asai, et al.,Neuroreport,8(9–10), 2305–2309 (1997).
D. Sugden,J. Pharmacol. Exp. Ther.,227, 587–591 (1983).
G. S. Arutyunyan, M. D. Mashkovskii, and L. F. Roshchina,Farmakol. Toksikol., No. 6, 650–655 (1963).
E. B. Arushanyan,Eksperim. Klin. Farmakol., No. 5, 72–77 (1992).
E. B. Arushanyan, L. G. Arushanyan, and K. B. Ovanesov,Farmakol. Toksikol., No. 5, 105–111 (1988).
E. B. Arushanyan and E. V. Beier,Eksperim. Klin. Farmakol., No. 2, 13–16 (1998).
S. Nomura, J. Shimizu, M. Kinjo, et al.,Eur. J. Pharmacol.,83, 171–175 (1982).
H.-A. Yamamoto and H. W. Tang,Neurosci. Lett. 207(2), 89–92 (1996).
J. Bures and O. Buresova,J. Comp. Physiol. Psychol.,56, 268–272 (1968).
K. B. Ovanesov,Farmakol. Toksikol., No. 2, 15–17 (1990).
F. Anton-Tay, C. Chou, S. Anton, and R. J. Wurtman,Science,162, 277–278 (1968).
A. Brzezinski, H. Y. Lynch, M. M. Seibel, et al.,J. Clin. Endocrinol.,66, 891–895 (1988).
H. Robert, R. Davis, L. Melonn, and Th. Vorskie,Proc. Soc. Exp. Biol. Med.,138(3), 1002–1004 (1971).
M. Quastel,Eur. J. Pharmacol., No. 6, 309–317 (1980).
R. L. Sack, A. Lewy, K. Parroff, et al.,Eur. J. Med. Chem.,30, 661–669 (1995).
D. Garfinkel,Lancet,346, 541 (1995).
M. A. Morozova, N. B. Zharkova, and M. Yu. Matyushova,Klin. Farmakol. Terap., No. 2, 69–71 (1996).
E. B. Arushanyan,Eksperim. Klin. Farmakol., No. 3, 67–70 (1998).
S. Capsoni, B. Stanikov, and F. Frasehini,Neuroreport,6(9), 1346–1348 (1995).
E. B. Arushanyan and E. M. Chernysheva,Eksperim. Klin. Farmakol., No. 1, 7–9 (1997).
E. B. Arushanyan and E. M. Arushanyan,Eksperim. Klin. Farmakol., No. 6, 71–77 (1997).
K. V. Sudakov,Terap. Arkhiv, No. 1, 70–74 (1997).
C. P. Maurizi,Med. Hypotheses,45(4), 334–340 (1995).
H. Bartsch, C. Bartsch, W. E. Simon, et al.,Oncology,49, 27–30 (1992).
D. A. Tan, B. Poeggeler, R. Reiter, et al.,Cancer Lett.,70, 65–71 (1993).
S. I. Rapoport,Klin. Med., No. 5, 14–17 (1997).
S. S. Pertsov, A. S. Sosnovskii, and G. V. Pirogova,Byul. Eksper. Biol. Med., No. 1, 12–17 (1998).
F. I. Komarov, S. I. Rapoport, and N. Ya. Malinovskaya,Klin. Med., No. 3, 15–18 (1998).
N. K. Zenkov, M. I. Dushkin, E. B. Men'shikova, et al.,Byul. Eksper. Biol. Med., No. 10, 399–402 (1996).
P. Brugger, W. Marktl, and M. Herold,Lancet,345, 1408 (1995).
D. J. Kennaway and C. F. Van Dorp,Am. J. Physiol.,260, R1137-R1144 (1991).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 33, No. 8, pp. 49–52, August, 1999.
Rights and permissions
About this article
Cite this article
Andreeva, N.I., Asnina, V.V. & Liberman, S.S. Melatonin: Pharmacological properties and clinical application. Pharm Chem J 33, 452–455 (1999). https://doi.org/10.1007/BF02510102
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02510102